ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 224 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,606,896 | +186.6% | 125,091 | +229.4% | 0.01% | +400.0% |
| Q2 2023 | $909,621 | -45.7% | 37,980 | -57.3% | 0.00% | -66.7% |
| Q1 2023 | $1,675,149 | +1026.7% | 89,009 | +853.1% | 0.00% | – |
| Q4 2022 | $148,676 | -23.0% | 9,339 | -21.2% | 0.00% | – |
| Q3 2022 | $193,000 | +16.3% | 11,852 | +0.5% | 0.00% | – |
| Q2 2022 | $166,000 | -89.0% | 11,794 | -81.1% | 0.00% | -100.0% |
| Q1 2022 | $1,507,000 | +9.7% | 62,260 | +5.7% | 0.00% | 0.0% |
| Q4 2021 | $1,374,000 | – | 58,911 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 82,723 | $2,685,000 | 20.75% |
| HWG Holdings LP | 289,380 | $9,393,000 | 8.72% |
| Baker Brothers Advisors | 24,516,738 | $795,813,000 | 8.34% |
| HARVEY CAPITAL MANAGEMENT INC | 352,200 | $11,432,000 | 5.73% |
| Belmont Global Advisors, Inc. | 150,000 | $4,869,000 | 4.67% |
| Palo Alto Investors LP | 1,437,730 | $46,669,000 | 3.52% |
| Avoro Capital Advisors LLC | 329,500 | $10,696,000 | 2.38% |
| GARRISON BRADFORD & ASSOCIATES INC | 70,100 | $2,275,000 | 2.23% |
| WEATHERBIE CAPITAL, LLC | 401,642 | $13,037,000 | 1.85% |
| ACUTA CAPITAL PARTNERS, LLC | 85,999 | $2,792,000 | 1.34% |